Gold nanotheranostics: future emblem of cancer nanomedicine. (October 2021)

• Record Type: Journal Article
• Authors: Navyatha, Bankuru; Nara, Seema
• Is Part Of: Nanobiomedicine. Volume 8(2021)
• Publication Date: 2021-10
• Subjects: Nanotheranostics -- nanocomposites -- photothermal therapy -- photostability -- toxicity; Nanomedicine -- Periodicals; Ultrastructure (Biology) -- Periodicals; Bioengineering -- Periodicals; 610.28
• DOI: 10.1177/18495435211053945
• Languages: English
• ISSNs: 1849-5435

Abstract

Cancer nanotheranostics aims at providing alternative approaches to traditional cancer diagnostics and therapies. In this context, plasmonic nanostructures especially gold nanostructures are intensely explored due to their tunable shape, size and surface plasmon resonance (SPR), better photothermal therapy (PTT) and photodynamic therapy (PDT) ability, effective contrast enhancing ability in Magnetic Resonance imaging (MRI) and Computed Tomography (CT) scan. Despite rapid breakthroughs in gold nanostructures based theranostics of cancer, the translation of gold nanostructures from bench side to human applications is still questionable. The major obstacles that have been facing by nanotheranostics are specific targeting, poor resolution and photoinstability during PTT etc. In this regard, various encouraging studies have been carried out recently to overcome few of these obstacles. Use of gold nanocomposites also overcomes the limitations of gold nanostructure probes and emerged as good nanotheranostic probe. Hence, the present article discusses the advances in gold nanostructures based cancer theranostics and mainly emphasizes on the importance of gold nanocomposites which have been designed to decipher the past questions and limitations of in vivo gold nanotheranostics.